Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of [S,S]-reboxetine vs routine care in postherpetic neuralgia
2006-001343-55Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of reboxetine in postherpetic neuralgia (PHN) (2 arms), sponsored by Pfizer. Primary endpoint: Vital signs. Started Jun 2006; status: completed.
02
Drugs
reboxetine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on 2006-001343-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001343-55.